ProPhase Labs, Inc. (PRPH)
Pharmaceutical Preparations
Latest Price
$0.36
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--
Valuation metrics
adjust assumptions →Base FCF: $25M (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$46.17
+12634% upside
Institutional Ownership
0.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| CoreCap Advisors, LLC | 10 | -- | 0.00% | -710 | 2026-03-31 |
| Farther Finance Advisors, LLC | 10 | -- | 0.00% | +1 | 2026-03-31 |